Mabylon AG
PrivateLast Round
VC Round
Aug 12, 2025
Total Funding Raised
$1.48M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mabylon AG is a biotechnology company that discovers and develops human-derived antibody therapeutics for the treatment of allergies, inflammation, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mabylon AG Comparables
Compare Mabylon AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IgGenix | 85% | |
| Dualitas Therapeutics | 78% | |
| Poplar Therapeutics | 77% | |
Mabylon AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 12, 2025 | ||||
| Grant | Sep 24, 2024 |
Key People
Founding team and executive leadership
Mabylon AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| NIH RADx | Grant |
| Eurostars SME programme | Grant |
| Target ALS | Grant |
| Innosuisse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 151% MoM.
- Apr 21, 2026
Monthly visitors grew 217% MoM, reaching 606.
Mabylon AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mabylon AG's valuation, stock price, and market status.